Novel substituted 1,5,7-trisubstituted-3,4-dihydro-pyrimido[4,5-d]pyrimidin-2-(1H)-one compounds and compositions, and their use in therapy as CSBP/RK/p38 kinase inhibitors.
小说替代了1,5,7-三取代-3,4-二氢
嘧啶[4,5-d]
嘧啶-2-(1H)-
酮类化合物和组合物,并将其用于治疗作为CSBP/RK/p38激酶
抑制剂。